Page 13 - Read Online
P. 13

Ishihara. Mini-invasive Surg 2021;5:36  https://dx.doi.org/10.20517/2574-1225.2021.72  Page 7 of 9

               recommended for these patients.


               FUTURE PERSPECTIVES
               Widespread use of ESD
               ESD has higher en bloc resection rate and R0 resection rate than EMR. However, piecemeal EMR is still
               conducted in some areas. Widespread use of ESD is desired by overcoming its technical difficulties.

               Best treatment for circumferential lesions
               ESD is a minimally invasive treatment with high curative potential in patients with esophageal cancer.
               However, circumferential endoscopic resection can result in intractable stenosis, considerably reducing the
               patient’s quality of life. Chemoradiotherapy is another option for circumferential lesions. A literature search
               failed to find any previous studies that described the specific survival rates of patients with circumferential
               lesions. Survival analyses and comparative studies of ESD and chemoradiotherapy for circumferential
               lesions are therefore required to determine the best treatment for circumferential lesions.

               Curability assessment for (p)MM cancer
               Assessing the curability of (p)MM cancer without vascular invasion is an issue in clinical practice. Previous
               studies  examining  the  incidence  of  metastasis  following  endoscopic  resection  were  conducted
               retrospectively, did not make it clear if the pathological evaluations were performed using immunostaining,
               and lacked thorough and long-term follow-up observations. Future prospective studies are anticipated to
               evaluate the metastasis rates in patients with (p)MM cancer based on detailed histological evaluations and
               intensive follow-up.


               Indication of additional treatment after ESD
               The indications for additional treatment are mainly determined based on the risk of metastasis and the
               patient’s condition. Considering our aging society, additional treatment may not be indicated even in
               patients with a substantial risk of metastasis. However, detailed stratification of metastasis risk based on
               histologic findings is currently not possible, and further studies are needed to develop factors to determine
               detailed individual risks of metastasis.

               Conclusion
               An accurate preoperative diagnosis, appropriate indication, and adequate curability assessment based on the
               pathological diagnosis of resected specimens are important for effective ESD.


               DECLARATIONS
               Acknowledgments
               I thank Susan Furness, PhD from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.


               Authors’ contributions
               The author contributed solely to the article.


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.
   8   9   10   11   12   13   14   15   16   17   18